Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

VLA-4 receptor-blocking drugs described by Zeneca

Aug. 30, 1996

Protease inhibitors described by Shionogi

Aug. 30, 1996

Antiherpes compounds from Bio-Mega/Boehringer Ingelheim

Aug. 30, 1996

Toyama reveals anti-HIV quinolones

Aug. 30, 1996

Tetromycin A: a novel antibacterial agent

Aug. 30, 1996

Antifungal agents from Hokko Kagaku

Aug. 30, 1996

Treatment for keratinization disorders described by Janssen

Aug. 30, 1996

Merck & Co. reports NK1 antagonists

Aug. 30, 1996

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996

Erythromycin A 9-O-oxime derivatives from Zambon

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.